Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyang Keli (also known as Skin Itching Granules) is a traditional Chinese medicine (TCM) granule formulation widely used in China for the treatment of skin pruritus (itching) and urticaria (hives). The formulation is composed of five active herbal ingredients: *Xanthium sibiricum* (Cang Er Zi), *Kochia scoparia* (Di Fu Zi), *Ligusticum chuanxiong* (Chuanxiong), *Carthamus tinctorius* (Safflower / Honghua), and *Solanum lyratum* (Baiying). It functions by expelling wind, promoting blood circulation, dehumidifying, and relieving itching. Fuyang Keli is manufactured and marketed by several pharmaceutical companies in China, including Shaanxi Momentum Pharmaceutical, Chengdu Dikang Pharmaceutical, and Sichuan Shenghe Pharmaceutical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuyang keli.